A link between imatinib resistance and TWIST1 exists, as in vitro knockdown of TWIST1 expression in CML cells resulted in sensitization for imatinib (Cosset et al., 2011). Here, TWIST1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.